Cabergoline targets multiple pathways to inhibit PRL secretion and increases stromal fibrosis.

Saved in:
Bibliographic Details
Title: Cabergoline targets multiple pathways to inhibit PRL secretion and increases stromal fibrosis.
Authors: Zhang D; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Hugo W; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Bergsneider M; Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Wang MB; Department of Head and Neck Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Kim W; Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Han K; Department of Pathology and Lab Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Vinters HV; Department of Pathology and Lab Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Heaney AP; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.; Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Source: European journal of endocrinology [Eur J Endocrinol] 2024 Jun 05; Vol. 190 (6), pp. 467-478.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9423848 Publication Model: Print Cited Medium: Internet ISSN: 1479-683X (Electronic) Linking ISSN: 08044643 NLM ISO Abbreviation: Eur J Endocrinol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1479-683X
DOI:10.1093/ejendo/lvae055